Mersana Therapeutics (MRSN) Prices 8M Share Common Offering at $19/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Mersana Therapeutics (MRNS) to Offer 5M Shares
May 28, 2020 6:03 AM EDTMersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering of 5 million shares of its common stock. All shares being offered are to be sold by Mersana. As part of the offering, Mersana intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock... More
Mersana (MRSN) PT Raised to $19 at Wedbush
May 27, 2020 12:42 PM EDTWedbush analyst David Nierengarten raised the price target on Mersana (NASDAQ: MRSN) to $19.00 (from $12.00) while maintaining an Outperform rating.
XMT-1536 Expansion Impresses: Broad, Deep and Deepening Responses in PROC... MorePre-Open Stock Movers 05/27: (HTZ) (PHUN) (MRSN) (STNE) (CPIX) (HTBX) (SAVE) (more...)
May 27, 2020 8:44 AM EDTToday's Pre-Open Stock Movers:
Hertz Global Holdings, Inc. (NYSE: HTZ) +58%; announced over the weekend it and certain of its U.S. and Canadian subsidiaries have filed voluntary petitions for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Phunware (NASDAQ: PHUN) +38%; announced today its strategic relationship with American Made Media Consultants on the development, launch and ongoing management and evolution of the Trump-Pence... More
Mersana Therapeutics (MRSN) Announces Positive Interim Data from Expansion Portion of the XMT-1536 Phase 1 Study
May 27, 2020 6:10 AM EDTMersana Therapeutics, Inc. (NASDAQ: MRSN) today reported interim safety, tolerability and efficacy data from the ongoing expansion portion of the Phase 1 study evaluating XMT-1536, its first-in-class ADC candidate targeting NaPi2b, in patients with ovarian cancer and non-small cell lung (NSCLC) adenocarcinoma. The Company will host a conference call and webcast today, Wednesday, May 27, 2020, at 8:00 a.m. ET during which investigator Debra L. Richardson, MD, Associate Professor of Gynecologic Oncology at the Stephenson Cancer Center at the University of Oklahoma Health Sciences Center and the Sarah Cannon Research Institute and members of the... More
